GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cyxone AB (OSTO:CYXO) » Definitions » Price-to-Tangible-Book

Cyxone AB (OSTO:CYXO) Price-to-Tangible-Book : 2.97 (As of May. 29, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Cyxone AB Price-to-Tangible-Book?

As of today (2024-05-29), Cyxone AB's share price is kr0.1365. Cyxone AB's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was kr0.05. Hence, Cyxone AB's Price to Tangible Book Ratio of today is 2.97.

The historical rank and industry rank for Cyxone AB's Price-to-Tangible-Book or its related term are showing as below:

OSTO:CYXO' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.46   Med: 4.43   Max: 24.41
Current: 2.73

During the past 8 years, Cyxone AB's highest Price to Tangible Book Ratio was 24.41. The lowest was 1.46. And the median was 4.43.

OSTO:CYXO's Price-to-Tangible-Book is ranked better than
51.23% of 1218 companies
in the Biotechnology industry
Industry Median: 2.83 vs OSTO:CYXO: 2.73

A closely related ratio is called PB Ratio. As of today, Cyxone AB's share price is kr0.1365. Cyxone AB's Book Value per Sharefor the quarter that ended in Mar. 2024 was kr0.16. Hence, Cyxone AB's P/B Ratio of today is 0.86.


Cyxone AB Price-to-Tangible-Book Historical Data

The historical data trend for Cyxone AB's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cyxone AB Price-to-Tangible-Book Chart

Cyxone AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Price-to-Tangible-Book
Get a 7-Day Free Trial 2.81 3.43 4.71 4.43 1.88

Cyxone AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.88 2.67 5.63 2.69 1.79

Competitive Comparison of Cyxone AB's Price-to-Tangible-Book

For the Biotechnology subindustry, Cyxone AB's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cyxone AB's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cyxone AB's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Cyxone AB's Price-to-Tangible-Book falls into.



Cyxone AB Price-to-Tangible-Book Calculation

Cyxone AB's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2024 )
=0.1365/0.046
=2.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Cyxone AB Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Cyxone AB's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Cyxone AB (OSTO:CYXO) Business Description

Traded in Other Exchanges
Address
Adelgatan 21, Malmo, SWE, 221 22
Cyxone AB is a clinical biotech company with a portfolio of immunomodulating drugs for the treatment of autoimmune diseases such as multiple sclerosis (MS) and rheumatoid arthritis (RA). The product candidates of the company include T20K and Rabeximod.

Cyxone AB (OSTO:CYXO) Headlines

No Headlines